Related Experiment Video
Updated: Aug 26, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Neuromodulatory mechanism underlying the effect of the atypical dipeptide neuroleptic dilept
M V Retyunskaya1, L S Guzevatykh, N A Bondarenko
1Institute of Pharmacology, Russian Academy of Medical Sciences.
Abstract:
We studied the effects of a new dipeptide neuroleptic Dilept (N-caproyl-L-prolyl-L-tyrosine methyl ester) on activity of neurotransmitter systems in the brain. Dilept possessed antidopamine, glutamate modulatory, and cholinomimetic properties. These data indicate that Dilept is of potential efficacy in relieving positive and negative symptoms of schizophrenia.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Antipsychotic Drugs: Typical and Atypical Agents
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
